Molecular matching of red blood cells is superior to serological matching in sickle cell disease patients

Abstract

Molecular matching is superior to serological matching in sickle cell disease patients, decreasing the risk of transfusion reactions, especially delayed transfusion reactions to existing alloantibodies and preventing alloimmunization.